A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.
Category: Proteins
-
A.I. Turns Its Artistry to Creating New Human Proteins
The New York Times – Business:Inspired by digital art generators like DALL-E, biologists are building artificial intelligences that can fight cancer, flu and Covid.